Table 2.
Distribution of Cases by Methadone or Buprenorphine and Duration Overlap With Linezolid
Overlap Duration <3 Days | Overlap Duration ≥3 Days | |||||
---|---|---|---|---|---|---|
Case | No | Possible | Definite | No | Possible | Definite |
Methadone | 321 | 0 | 0 | 88 | 2 | 0 |
Buprenorphine | 63 | 0 | 0 | 15 | 0 | 0 |
Both | 4 | 0 | 0 | 1 | 0 | 0 |